By integrating RNA sequencing, mass spectrometry and in vitro/in vivo experiments, the study revealed that low TNFα levels in these regions promoted glioma stem cell self‐renewal via Vasorin‐mediated glycolysis, contributing to therapy resistance and highlighting the potential of targeting both TNFα and Vasorin pathways as a potential therapeutic strategy. The gene discussed is VASN; the disease is glioma.